NCT02882581View on ClinicalTrials.gov

Metformin in Breast Cancer, Visualized With Positron Emission Tomography

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

October 31, 2017

Conditions
Breast Cancer
Interventions
RADIATION

11C-metformin

400MBq of 11C-metformin is injected in the cubital vein. The participant is then scanned for 120 min using Position Emission Tomography.

Trial Locations (2)

DK-8000

Department of Nuclear Medicine & PET-center, Aarhus University Hospital, Aarhus

Department of Surgery, Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

Aarhus University Hospital

OTHER

NCT02882581 - Metformin in Breast Cancer, Visualized With Positron Emission Tomography | Biotech Hunter | Biotech Hunter